BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28027311)

  • 1. Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution.
    Van den Eynden J; Basu S; Larsson E
    PLoS Genet; 2016 Dec; 12(12):e1006506. PubMed ID: 28027311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome.
    Zapata L; Pich O; Serrano L; Kondrashov FA; Ossowski S; Schaefer MH
    Genome Biol; 2018 May; 19(1):67. PubMed ID: 29855388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
    Zhao M; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Patterns of Selection in Cancer and Somatic Tissues.
    Martincorena I; Raine KM; Gerstung M; Dawson KJ; Haase K; Van Loo P; Davies H; Stratton MR; Campbell PJ
    Cell; 2017 Nov; 171(5):1029-1041.e21. PubMed ID: 29056346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for estimating the intensity of purifying selection in protein-coding genes.
    Ophir R; Itoh T; Graur D; Gojobori T
    Mol Biol Evol; 1999 Jan; 16(1):49-53. PubMed ID: 10331251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer evolution is associated with pervasive positive selection on globally expressed genes.
    Ostrow SL; Barshir R; DeGregori J; Yeger-Lotem E; Hershberg R
    PLoS Genet; 2014 Mar; 10(3):e1004239. PubMed ID: 24603726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of Deleterious Mutations Near Sexually Antagonistic Genes.
    Connallon T; Jordan CY
    G3 (Bethesda); 2016 Aug; 6(8):2273-84. PubMed ID: 27226163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genes.
    Kumar RD; Burns BA; Vandeventer PJ; Luna PN; Shaw CA
    Cancer Genet; 2021 Nov; 258-259():80-84. PubMed ID: 34592632
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
    [No Abstract]   [Full Text] [Related]  

  • 11. The guardians of inherited oncogenic vulnerabilities.
    Arnal A; Tissot T; Ujvari B; Nunney L; Solary E; Laplane L; Bonhomme F; Vittecoq M; Tasiemski A; Renaud F; Pujol P; Roche B; Thomas F
    Evolution; 2016 Jan; 70(1):1-6. PubMed ID: 26519218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purifying selection in mammalian mitochondrial protein-coding genes is highly effective and congruent with evolution of nuclear genes.
    Popadin KY; Nikolaev SI; Junier T; Baranova M; Antonarakis SE
    Mol Biol Evol; 2013 Feb; 30(2):347-55. PubMed ID: 22983951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric.
    Van den Eynden J; Larsson E
    Front Genet; 2017; 8():74. PubMed ID: 28642787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.
    Cheng F; Jia P; Wang Q; Lin CC; Li WH; Zhao Z
    Mol Biol Evol; 2014 Aug; 31(8):2156-69. PubMed ID: 24881052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples.
    Gorlov IP; Pikielny CW; Frost HR; Her SC; Cole MD; Strohbehn SD; Wallace-Bradley D; Kimmel M; Gorlova OY; Amos CI
    BMC Bioinformatics; 2018 Nov; 19(1):430. PubMed ID: 30453881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of variation in cis-regulatory regions: examining evidence of purifying selection.
    Naidoo T; Sjödin P; Schlebusch C; Jakobsson M
    BMC Genomics; 2018 Jan; 19(1):95. PubMed ID: 29373957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Driver Interfaces Enriched for Somatic Missense Mutations in Tumors.
    Ozturk K; Carter H
    Methods Mol Biol; 2019; 1907():51-72. PubMed ID: 30542990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective pressures at a codon-level predict deleterious mutations in human disease genes.
    Arbiza L; Duchi S; Montaner D; Burguet J; Pantoja-Uceda D; Pineda-Lucena A; Dopazo J; Dopazo H
    J Mol Biol; 2006 May; 358(5):1390-404. PubMed ID: 16584746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.